(2) | (47) | " (5) | # (2) | $ (1) | 0 (43) | 1 (528) | 2 (598) | 3 (345) | 4 (27) | 5 (21) | 6 (14) | 7 (7) | 8 (3) | 9 (4) | < (49) | A (337) | B (71) | C (274) | D (142) | E (194) | F (157) | G (462) | H (72) | I (179) | J (46) | K (72) | L (87) | M (208) | N (154) | O (61) | P (278) | Q (10) | R (117) | S (501) | T (563) | U (134) | V (38) | W (308) | X (9) | Y (15) | Z (8) |   (1) | Д (1) | П (1) | С (1) | إ (1) | ‘ (2) | “ (1)
Title Last update
Policies and practical guidance Mon, 05/27/2024 - 05:13
Planning and programme management Mon, 05/27/2024 - 04:31
Political Declaration of the High-level Meeting on Antimicrobial Resistance Fri, 05/24/2024 - 05:50
Private Sector Providers Constituency Delegation to the Stop TB Partnership Board Sat, 05/18/2024 - 03:02
Priority TB CRG Interventions for the Global Fund Application (French) Wed, 04/03/2024 - 06:49
Practical considerations for implementation of the BD MAX MDR-TB test Tue, 04/02/2024 - 07:19
Practical considerations for implementation of the Roche cobas MTB and cobas MTB-RIF/INH assays Tue, 04/02/2024 - 07:18
Practical considerations for implementation of the Abbott RealTime MTB and Abbott RealTime MTB RIF/INH tests Tue, 04/02/2024 - 07:18
Practical considerations for implementation of the Bruker-Hain Lifesciences FluoroType MTB and FluoroType MTBDR Tue, 04/02/2024 - 07:17
Practical considerations for implementation of the Cepheid Xpert MTB/XDR test Tue, 04/02/2024 - 07:16
Practical considerations for implementation of the Nipro Genoscholar PZA-TB II assay Tue, 04/02/2024 - 07:16
Practical considerations for implementation of the loop-mediated isothermal amplification (TB-LAMP) test Tue, 04/02/2024 - 07:15
Personal respiratory protection (Spanish version) Wed, 03/27/2024 - 09:47
Partners In Health Mon, 03/25/2024 - 05:26
Plan an Order Mon, 02/26/2024 - 06:47
Planning and Budgeting Tool for TB and drug resistant TB testing Thu, 02/22/2024 - 06:30
Planning and budgeting tool for TB and drug resistant TB testing: calculation tool Thu, 02/22/2024 - 06:18
Previous CFCS Funding Rounds Mon, 02/12/2024 - 10:06
Philiphines test Wed, 02/07/2024 - 04:16
prueba valentines Fri, 02/02/2024 - 13:41
prueba valentines Fri, 02/02/2024 - 13:40
prueba valentines Fri, 02/02/2024 - 13:38
Patient flow & building design. Theory to practice, Jako Nice Thu, 01/25/2024 - 04:37
Prioritise People, Human Rights & Gender Wed, 01/24/2024 - 13:17
Press tour to Mozambique Mon, 01/08/2024 - 04:42
Professor Charles Daley, MD, elected as Chair of the Core Group of Global Drug-resistant TB Initiative (GDI) Thu, 12/21/2023 - 07:14
People-centered Design Toolkit Tue, 12/05/2023 - 05:43
Promote Human Rights in TB Mon, 11/27/2023 - 17:26
Practical manual of processing stool samples for diagnosis of childhood TB Tue, 11/21/2023 - 06:41
Practical manual of processing stool samples for diagnosis of childhood TB Tue, 11/21/2023 - 06:40
prueba Tue, 11/14/2023 - 04:07
Perspectives and Lessons from SUFT Project Fri, 11/03/2023 - 08:06
Prevalence and screening of active tuberculosis in a prison in the South of Brazil Fri, 11/03/2023 - 05:03
Pooled testing of sputum with Xpert MTB/ RIF and Xpert Ultra during tuberculosis active case finding campaigns in Lao People’s Democratic Republic Fri, 11/03/2023 - 04:44
Pooling sputum samples for Xpert® MTB/RIF and Xpert® Ultra testing for TB diagnosis Thu, 11/02/2023 - 08:05
Pooling samples to increase testing capacity with Xpert Xpress SARS-CoV-2 during the Covid-19 pandemic in Lao People’s Democratic Republic Thu, 11/02/2023 - 08:05